Valcenko A, Zwick A, Schneider L, Linxweiler M, et al. The tumor cell killing capacity of head and neck cancer patient-derived neutrophils depends on tumor stage, gender and the antibody isotype. Oral Oncol 2024;159:107042.
PMID: 39306937